Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

KLSE:MGRC Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Revenue	8.02	5.52	9.57	8.36	28.36
Revenue Growth (YoY)	45.29%	-42.32%	14.47%	-70.51%	1490.09%
Cost of Revenue	2.82	2.09	3.98	3.26	14.51
Gross Profit	5.21	3.43	5.59	5.1	13.85
Selling, General & Admin	6.1	8.12	25.51	11.12	7.83
Operating Expenses	7.62	8.12	25.51	18.65	7.83
Operating Income	-2.42	-4.69	-19.92	-13.55	6.02
Interest Expense	-0.1	-0.12	-0.1	-0.1	-0.1
Other Non Operating Income (Expenses)	0.02	0.29	0.03	0.06	0.26
Pretax Income	-2.49	-4.51	-20	-13.59	6.18
Income Tax Expense	0.31	0	1.15	1.15	-1.03
Earnings From Continuing Operations	-2.8	-4.51	-21.15	-14.74	7.21
Net Income to Company	-2.8	-4.51	-21.15	-14.74	7.21
Minority Interest in Earnings	0.42	0.32	2.1	0.5	0
Net Income	-2.38	-4.19	-19.05	-14.25	7.21
Net Income to Common	-2.38	-4.19	-19.05	-14.25	7.21
Shares Outstanding (Basic)	137	137	161	128	123
Shares Outstanding (Diluted)	137	137	161	128	123
Shares Change (YoY)	-	-14.93%	26.44%	3.69%	14.37%
EPS (Basic)	-0.02	-0.03	-0.12	-0.11	0.06
EPS (Diluted)	-0.02	-0.03	-0.12	-0.11	0.06
Free Cash Flow	0.89	-0.95	-17.04	-22.51	-1.27
Free Cash Flow Per Share	0.01	-0.01	-0.11	-0.18	-0.01
Gross Margin	64.88%	62.09%	58.39%	60.98%	48.84%
Operating Margin	-30.10%	-84.87%	-208.08%	-162.05%	21.24%
Profit Margin	-29.69%	-75.90%	-198.96%	-170.32%	25.42%
Free Cash Flow Margin	11.07%	-17.12%	-177.98%	-269.11%	-4.49%
EBITDA	-1.33	-3.49	-18.57	-12.19	6.82
EBITDA Margin	-16.55%	-63.22%	-193.96%	-145.73%	24.05%
D&A For EBITDA	1.09	1.2	1.35	1.37	0.8
EBIT	-2.42	-4.69	-19.92	-13.55	6.02
EBIT Margin	-30.10%	-84.87%	-208.08%	-162.05%	21.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.